Vertex Pharmaceuticals (VRTX) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,178.57% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.45% |
| Dec 31, 2025 | 31.44% |
| Sep 30, 2025 | 4.74% |
| Jun 30, 2025 | 128.66% |
| Mar 31, 2025 | -40.86% |
| Dec 31, 2024 | -4.85% |
| Sep 30, 2024 | 1.01% |
| Jun 30, 2024 | -495.45% |
| Mar 31, 2024 | 56.51% |
| Dec 31, 2023 | 18.15% |
| Sep 30, 2023 | 10.58% |
| Jun 30, 2023 | 12.46% |
| Mar 31, 2023 | -9.12% |
| Dec 31, 2022 | 5.37% |
| Sep 30, 2022 | 9.45% |
| Jun 30, 2022 | 1,103.85% |
| Mar 31, 2022 | 18.88% |
| Dec 31, 2021 | 29.57% |
| Sep 30, 2021 | 29.64% |
| Jun 30, 2021 | -91.82% |
| Mar 31, 2021 | 8.73% |
| Dec 31, 2020 | 3.14% |
| Sep 30, 2020 | 1,050.00% |
| Jun 30, 2020 | 208.74% |
| Mar 31, 2020 | 122.33% |
| Dec 31, 2019 | -62.65% |
| Sep 30, 2019 | -56.00% |
| Jun 30, 2019 | 28.75% |
| Mar 31, 2019 | 27.16% |
| Dec 31, 2018 | 1,430.77% |
| Sep 30, 2018 | 221.95% |
| Jun 30, 2018 | 1,042.86% |
| Mar 31, 2018 | -18.18% |
| Dec 31, 2017 | 200.00% |
| Sep 30, 2017 | -156.25% |
| Jun 30, 2017 | 126.92% |
| Mar 31, 2017 | 682.35% |
| Dec 31, 2016 | 141.94% |
| Sep 30, 2016 | 58.97% |
| Jun 30, 2016 | 66.67% |
| Mar 31, 2016 | 79.52% |
| Dec 31, 2015 | 58.11% |
| Sep 30, 2015 | 45.83% |
| Jun 30, 2015 | -14.71% |
| Mar 31, 2015 | 17.00% |
| Dec 31, 2014 | -489.47% |
| Sep 30, 2014 | -33.33% |
| Jun 30, 2014 | -161.54% |
| Mar 31, 2014 | 30.07% |
| Dec 31, 2013 | 154.29% |
| Sep 30, 2013 | -100.00% |
| Jun 30, 2013 | 16.13% |
| Mar 31, 2013 | -432.56% |
| Dec 31, 2012 | -147.30% |
| Sep 30, 2012 | -126.47% |
| Mar 31, 2012 | 149.43% |
| Dec 31, 2011 | 182.22% |
| Sep 30, 2011 | 198.08% |
| Mar 31, 2011 | -4.82% |
| Dec 31, 2010 | -4.65% |
| Sep 30, 2010 | -23.81% |
| Jun 30, 2010 | -1.01% |
| Mar 31, 2010 | 20.19% |